# FDA Inspection 1083116 - Sircle Laboratories, L.L.C. - March 19, 2019

Source: https://www.keypedia.com/records/fda_inspections/sircle-laboratories-llc/2d1fa18c-0a23-4f80-8aa3-2b865d8b2efd
Source feed: FDA_Inspections

> FDA Inspection 1083116 for Sircle Laboratories, L.L.C. on March 19, 2019. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1083116
- Company Name: Sircle Laboratories, L.L.C.
- Inspection Date: 2019-03-19
- Classification: Official Action Indicated (OAI)
- Project Area: Unapproved and Misbranded Drugs
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1179727 - 2022-09-16](https://www.keypedia.com/records/fda_inspections/sircle-laboratories-llc/5cb5971d-cf20-4517-a6e8-75739bdb3f48)
- [FDA Inspection 1140698 - 2021-04-26](https://www.keypedia.com/records/fda_inspections/sircle-laboratories-llc/de6edd97-a9ba-4734-9df3-55c6d2ea62ff)
- [FDA Inspection 1083116 - 2019-03-19](https://www.keypedia.com/records/fda_inspections/sircle-laboratories-llc/590b8e25-4b92-4d95-a841-ab7849121390)

Company: https://www.keypedia.com/companies/sircle-laboratories-llc/b5a76d52-ab2d-42aa-ac2f-012952d6e6b4

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c